Speaking about GDP growth, Sitharaman said in the three years prior to 2024-25, the country's GDP growth rate averaged about ...

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...

Finance Minister Nirmala Sitharaman highlights India's economic rebound and commitment to remaining the world's ...

Wedbush analyst Scott Devitt wrote that Shopify posted "solid results vs. great expectations" while flagging that there's likely "some level of conservatism" in the guidance. Shopify's growth for the ...

Adyen (OTC: ADYE.Y) gained a lot of attention in 2018 when eBay (NASDAQ: EBAY) chose the Dutch payment processor to replace ...

The policy space arising out of the rate cut coupled with credit uptake and prudent fiscal operation would help in evolving ...

More than a month into 2025, investors have plenty of earnings to digest. Many of the most notable “Magnificent 7” tech ...

U.S.-listed shares of the company, having jumped 13% so far this year driven by investors' optimism around the company's ...

Motorola Solutions has shown impressive growth, and its products ensure continued demand and revenue stability. Learn why MSI ...

Dynagas' recent unit repurchase program and current stock price suggest the stock is undervalued. Learn why DLNG stock is a ...

The Medford-based, family owned contractor generated more than $800 million in revenue last year, a new record, per chief ...

Australian biopharmaceutical company CSL posted higher first-half profits as growth in its main blood-plasma business helped offset weaker flu vaccine sales, which were hit by "significantly" low ...